With a wide range of innovative clinical care, research, education and training programs, the Division of Infectious Diseases is one of the nation's leading programs in the field. We have a deep commitment to promoting diversity, equity and inclusion among our staff, faculty and trainees as well as in clinical care and research.
Our division comprises world-class experts in the diagnosis and treatment of infectious diseases. In order to optimize patient care, our specialists often collaborate with members of other specialties at Brigham and Women's Hospital and at Dana-Farber Cancer Institute (DFCI).
For instance, our clinicians hold regular clinics with the heart and lung transplant programs at the Brigham and Woman’s Hospital and Dana-Farber Cancer Institute (DFCI) infectious diseases immunocompromised host inpatient and outpatient clinics. We work closely with DFCI clinicians to manage clinical care and coordinate the timing of appointments for enhanced patient convenience while also seeing patients during and after hospital stays to ensure seamlessness of care.
Similarly, we have partnerships with the Brigham's Division of Women's Health and Department of Obstetrics and Gynecology. Our providers also hold clinics at Brigham Health's Fish Center for Women's Health, offering preconception infectious health counseling along with prenatal and postpartum care to pregnant people with infectious diseases issues.
Since 1991, the Brigham has offered a medical home model for patients with HIV. We follow over 650 patients, delivering primary care for some and consultative care for others. Collaboration with services such as neurology, dermatology, psychiatry, addiction medicine and social work is a hallmark of this program.
A multidisciplinary approach is also central to our management of complex lung infections, like nontuberculous mycobacteria (NTM), bacteria commonly found in soil, water and dust, in which we collaborate with Brigham pulmonologists on the challenges of patient care.
Outside the realm of clinical care, our clinician-scientists are building upon the Brigham's impressive legacy in infectious diseases research. Through basic and translational research, we seek to expand our knowledge of the scientific basis of disease and bring our findings into clinical practice. We also conduct clinical trials that not only give participants access to cutting-edge therapies, but also are designed to meet urgent patient needs and directly affect health and well-being.
Finally, our faculty are committed to educating and training the next generation of leaders in the field, including through the Mass General Brigham Infectious Diseases Fellowship Program.
Our division includes over 50 faculty members and roughly 50 trainees.
Dr. Daniel Kuritzkes, the Harriet Ryan Albee Professor of Medicine at Harvard Medical School, has served as division chief since 2012. He is the immediate past chair of the AIDS Clinical Trials Group, an international network funded by the National Institutes of Health that conducts clinical trials of novel therapeutics in HIV/AIDS, tuberculosis and viral hepatitis. In addition, he is a co-principal investigator of the Boston HIV Clinical Trials Unit and co-directs the Harvard University Center for AIDS Research Program in HIV Eradication.
Dr. Paul Sax, the Bruce A. Beal and Robert L. Beal Distinguished Chair of Infectious Diseases and the division's clinical director, leads the Brigham's HIV Program and is an internationally recognized expert in HIV clinical care. In addition to his clinical roles, Dr. Sax serves as co-director of the joint Mass General Brigham Infectious Diseases Fellowship Program. He is also course director for the division's postgraduate course and has represented the division as a visiting professor at several academic medical centers.
Dr. Lindsey Baden is director of the Brigham infectious diseases immunocompromised host inpatient and outpatient consultative services, a collaboration with DFCI. He is also program leader for the Hub and Network components of the Harvard Catalyst and has a prominent role in the HIV Vaccine Trials Network and the COVID-19 Prevention Network (CoVPN).
Dr. Jennifer A. Johnson is director of the division's ambulatory clinic at Brigham Medical Specialties, an assistant professor of medicine at Harvard Medical School and a co-investigator for vaccine studies conducted by the Boston HIV Clinical Trials Unit and CoVPN. She also serves as medical director of the Brigham Antibiotic Stewardship Program.
For over a century, a leader in patient care, medical education and research, with expertise in virtually every specialty of medicine and surgery.